Prevalence of celiac disease in Iranian patients with irritable bowel syndrome: A cross-sectional study

Journal of Digestive Diseases

Volumn 15, Issue 1, 2014, Pages 12-17

  Shayesteh, Ali Akbar ^a   Hajiani, Eskandar ^a   Hashemi, Seyed Jalal ^a   Masjedizadeh, Abdolrahim ^a   Latifi, Seyed Mahmod ^a   Shayesteh, Mehdi ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti gliadin antibody; Anti tissue transglutaminase antibody; Celiac disease; Irritable bowel syndrome; Rome III criteria

Indexed keywords

GLIADIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A TISSUE TRANSGLUTAMINASE ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CELIAC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIARRHEA; DIGESTIVE TRACT ENDOSCOPY; DUODENUM BIOPSY; FEMALE; GASTRODUODENOSCOPY; HUMAN; IRAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

ANTI-GLIADIN ANTIBODY; ANTI-TISSUE TRANSGLUTAMINASE ANTIBODY; CELIAC DISEASE; IRRITABLE BOWEL SYNDROME; ROME III CRITERIA;

ADULT; CELIAC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IRAN; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREVALENCE;

EID: 84889680374     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12102     Document Type: Article

References (32)

1. El-Salhy M. Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol 2012; 18: 5151-5163.
2. Choung RS, Locke GR 3rd. Epidemiology of IBS. Gastroenterol Clin North Am 2011; 40: 1-10.
3. Gwee KA, Wee S, Wong ML, Png DJ. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol 2004; 99: 924-931.
4. Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol 2009; 24: 1601-1607.
5. Hoseini-Asl MK, Amra B. Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol 2003; 22: 215-216.
6. Roshandel D, Rezailashkajani M, Shafaee S, Zali MR. Symptom patterns and relative distribution of functional bowel disorders in 1, 023 gastroenterology patients in Iran. Int J Colorectal Dis 2006; 21: 814-825.
7. Sorouri M, Pourhoseingholi MA, Vahedi M etal. Functional bowel disorders in Iranian population using Rome III criteria. Saudi J Gastroenterol 2010; 16: 154-160.
8. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-1390.
9. Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009; 137: 1912-1933.
10. Rostami Nejad M, Rostami K, Pourhoseingholi MA etal. Atypical presentation is dominant and typical for coeliac disease. J Gastrointestin Liver Dis 2009; 18: 285-291.
11. Jadallah KA, Khader YS. Celiac disease in patients with presumed irritable bowel syndrome: a case-finding study. World J Gastroenterol 2009; 15: 5321-5325.
12. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002; 346: 180-188.
13. American Gastroenterology Association. American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology 2002; 123: 2105-2107.
14. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185-1194.
15. Shahbazkhani B, Forootan M, Merat S etal. Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18: 231-235.
16. Shahbazkhani B, Malekzadeh R, Sotoudeh M etal. High prevalence of coeliac disease in apparently healthy Iranian blood donors. Eur J Gastroenterol Hepatol 2003; 15: 475-478.
17. Saberi-Firouzi M, Omrani GR, Nejabat M, Mehrabani D, Khademolhosseini F. Prevalence of celiac disease in Shiraz, southern Iran. Saudi J Gastroenterol 2008; 14: 135-138.
18. Emami M, Kouhestani S, Gholamrezaei A etal. Prevalence of celiac disease in patients with irritable bowel syndrome. Govaresh 2011; 13: 192-197.
19. Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the 'no man's land' of gluten sensitivity. Am J Gastroenterol 2009; 104: 1587-1594.
20. Carroccio A, Mansueto P, Iacono G etal. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol 2012; 107: 1898-1906; quiz 1907.
21. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Int Med 2009; 169: 651-658.
22. Korkut E, Bektas M, Oztas E, Kurt M, Cetinkaya H, Ozden A. The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome. Eur J Int Med 2010; 21: 389-392.
23. Sanders DS, Patel D, Stephenson TJ etal. A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 2003; 15: 407-413.
24. Ozdil K, Sokmen M, Ersoy O etal. Association of gluten enteropathy and irritable bowel syndrome in adult Turkish population. Digest Dis Sci 2008; 53: 1852-1855.
25. Cash BD, Rubenstein JH, Young PE etal. The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls. Gastroenterology 2011; 141: 1187-1193.
26. Rostami Nejad M, Rostami K, Emami MH, Zali MR, Malekzadeh R. Epidemiology of celiac disease in Iran: a review. Middle East J Dig Dis 2011; 3: 5-12.
27. Norris JM, Barriga K, Hoffenberg EJ etal. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 2005; 293: 2343-2351.
28. Ersryd A, Posserud I, Abrahamsson H, Simrén M. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III. Aliment Pharmacol Ther 2007; 26: 953-961.
29. Green PHR, Jabri B. Coeliac disease. Lancet 2003; 362: 383-391.
30. Husby S, Koletzko S, Korponay-Szabó IR etal.; ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54: 136-160.
31. Rostom A, Dubé C, Cranney A etal. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005; 128: S38-S46.
32. Lock RJ, Stevens S, Pitcher MC, Unsworth DJ. Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease? Eur J Gastroenterol Hepatol 2004; 16: 467-470.